FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Laboratory Values Cancer Trial Eligibility Criteria

FDA publishes a draft guidance with recommendations for increasing cancer drug trial participant diversity by selecting appropriate laboratory values ...

latest-news-card-1
Medical Devices

Cardinal Health Monoject Inspection Violations

FDA warns Cardinal Health it is distributing unapproved medical devices that also have a Quality System Regulation violation.

latest-news-card-1
Medical Devices

InfuTronix Recalls Malfunctioning Infusion Pumps

InfuTronix recalls its Nimbus infusion pump systems due to multiple potential failure modes that may include battery failure, upstream blockage (occlu...

latest-news-card-1
Medical Devices

Expanse ICE Clot Aspiration Device Cleared

FDA clears an Expanse ICE 510(k) for the ICE Aspiration System for use in peripheral thrombectomy procedures.

latest-news-card-1
Human Drugs

Amneal Generic OTC Narcan Spray OKd

FDA approves an Amneal Pharmaceuticals ANDA for a generic over-the-counter naloxone hydrochloride nasal spray, 4mg, (generic Narcan) for treating a dr...

latest-news-card-1
Human Drugs

Cut Ozempic/Wegovy Price: HELP Committee

Sen. Bernie Sanders and the HELP Committee call on Novo Nordisk to significantly reduce the cost of its Ozempic and Wegovy in the U.S.

latest-news-card-1
Medical Devices

Curio Postpartum Depression Device Cleared

FDA clears a Curio Digital Therapeutics 510(k) for its MamaLift Plus, a prescription digital therapeutic for treating postpartum depression.

latest-news-card-1
Human Drugs

Zydus Lifesciences Issued Another FDA-483

An FDA inspection at Zydus Lifesciences injectable manufacturing site in Jarod, India results in a 10-observation Form FDA-483, the second received by...

latest-news-card-1
Human Drugs

Dr. Reddys Recalls Sapropterin Dihydrochloride

Dr. Reddys Laboratories recalls six lots of sapropterin dihydrochloride powder for oral solution 100 mg due to decreased potency.

latest-news-card-1
Human Drugs

Pivya Approved for Uncomplicated UTIs

FDA approves Utility Therapeutics Pivya for some uncomplicated urinary tract infections.